MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹501 Cr | ₹402 Cr | ₹321 Cr | ₹456 Cr | ₹404 Cr |
What is the latest Total Current Liabilities ratio of MOREPEN LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹501 Cr |
Mar2024 | ₹402 Cr |
Mar2023 | ₹321 Cr |
Mar2022 | ₹456 Cr |
Mar2021 | ₹404 Cr |
How is Total Current Liabilities of MOREPEN LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹501 Cr | 24.53 | |
Mar2024 | ₹402 Cr | 25.18 | |
Mar2023 | ₹321 Cr | -29.64 | |
Mar2022 | ₹456 Cr | 13.04 | |
Mar2021 | ₹404 Cr | - |
Compare Total Current Liabilities of peers of MOREPEN LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MOREPEN LABORATORIES | ₹2,694.5 Cr | 2.3% | -9.2% | -43.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,560.0 Cr | 2.2% | 2.1% | -10.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,033.0 Cr | 0.3% | 6.4% | 8.7% | Stock Analytics | |
CIPLA | ₹134,400.0 Cr | 6.8% | 5.6% | 5.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,507.0 Cr | 1.6% | -1.1% | 5.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,628.0 Cr | 4.6% | -2.5% | -4.3% | Stock Analytics |
MOREPEN LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MOREPEN LABORATORIES | 2.3% |
-9.2% |
-43.9% |
SENSEX | 2.9% |
1.7% |
3.6% |
You may also like the below Video Courses